Pupa SM - Search Results

1

Role of HER2 gene overexpression in breast carcinoma.

Ménard S, Tagliabue E, Campiglio M, Pupa SM. Ménard S, et al. Among authors: pupa sm. J Cell Physiol. 2000 Feb;182(2):150-62. doi: 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E. J Cell Physiol. 2000. PMID: 10623878 Review.

2

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.

Castagnoli L, Ghedini GC, Koschorke A, Triulzi T, Dugo M, Gasparini P, Casalini P, Palladini A, Iezzi M, Lamolinara A, Lollini PL, Nanni P, Chiodoni C, Tagliabue E, Pupa SM. Castagnoli L, et al. Among authors: pupa sm. Oncogene. 2017 Mar 23;36(12):1721-1732. doi: 10.1038/onc.2016.338. Epub 2016 Sep 19. Oncogene. 2017. PMID: 27641338 Free PMC article.

3

Role of exon-16-deleted HER2 in breast carcinomas.

Castiglioni F, Tagliabue E, Campiglio M, Pupa SM, Balsari A, Ménard S. Castiglioni F, et al. Among authors: pupa sm. Endocr Relat Cancer. 2006 Mar;13(1):221-32. doi: 10.1677/erc.1.01047. Endocr Relat Cancer. 2006. PMID: 16601290

4

The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.

Berno V, Porrini D, Castiglioni F, Campiglio M, Casalini P, Pupa SM, Balsari A, Ménard S, Tagliabue E. Berno V, et al. Among authors: pupa sm. Endocr Relat Cancer. 2005 Jun;12(2):393-406. doi: 10.1677/erc.1.00870. Endocr Relat Cancer. 2005. PMID: 15947111

5

Role of HER2/neu in tumor progression and therapy.

Ménard S, Casalini P, Campiglio M, Pupa SM, Tagliabue E. Ménard S, et al. Among authors: pupa sm. Cell Mol Life Sci. 2004 Dec;61(23):2965-78. doi: 10.1007/s00018-004-4277-7. Cell Mol Life Sci. 2004. PMID: 15583858 Review.

6

Monoclonal antibody to fibulin-1 generated by genetic immunization.

Pupa SM, Forti S, Invernizzi AM, Giovanazzi R, Twal WO, Argraves WS, Ménard S. Pupa SM, et al. J Cell Biochem. 2003 Jul 1;89(4):647-52. doi: 10.1002/jcb.10563. J Cell Biochem. 2003. PMID: 12858331

7

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.

Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, Astolfi A, Musiani P, Forni G, Lollini PL. Nanni P, et al. Among authors: pupa sm. J Exp Med. 2001 Nov 5;194(9):1195-205. doi: 10.1084/jem.194.9.1195. J Exp Med. 2001. PMID: 11696586 Free PMC article.

8

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.

Pupa SM, Invernizzi AM, Forti S, Di Carlo E, Musiani P, Nanni P, Lollini PL, Meazza R, Ferrini S, Menard S. Pupa SM, et al. Gene Ther. 2001 Jan;8(1):75-9. doi: 10.1038/sj.gt.3301360. Gene Ther. 2001. PMID: 11402305

9

Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients.

Pupa SM, Ménard S, Andreola S, Colnaghi MI. Pupa SM, et al. Cancer Res. 1993 Dec 15;53(24):5864-6. Cancer Res. 1993. PMID: 7903196

10

Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cells.

Pupa SM, Canevari S, Fontanelli R, Ménard S, Mezzanzanica D, Lanzavecchia A, Colnaghi MI. Pupa SM, et al. Int J Cancer. 1988 Sep 15;42(3):455-9. doi: 10.1002/ijc.2910420324. Int J Cancer. 1988. PMID: 2971021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results